Delivery Order SPE2DB24D2012-SPE2DB25FBVBC

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,398.86, is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,233.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664445 - Cyclosporine 0.05% eye emulsion. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cyclosporine 0.05% eye emulsion. The $4,820.52 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a $5,874.63 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4564815332 - CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566862227 - CYCLOSPORINE 0.05% EYE EMULS 30S, a medical product used for eye care. The contract has a ceiling value of $2,272.91 and is a Firm Fixed Price Delivery Order with an ultimate completion date of January 8, 2025. The contract is not designated with a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,079.09 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with a completion date of November 18, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,568.53 firm fixed-price contract is for the delivery of 4566848748 - Cyclosporine 0.05% Eye Emulsion 30s, a specialty pharmaceutical product. The contract has an ultimate completion date of January 7, 2025 and was awarded on January 6, 2025. This appears to be a task order under a larger Indefinite...
This federal contract award, valued at $2,227.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialized ophthalmic medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,749,185 units of Cyclosporine 0.05% eye emulsion in 30-count packs. The $2,094.85 firm fixed-price Delivery Order was issued by the Defense Logistics Agency (DLA), a defense agency, on December 17, 2024, with a completion date of December 18, 2024. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVBC
    Delivery Order

This is a $18,302.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566859529 CYCLOSPORINE 0.05% EYE EMULSION 60S, with a performance period through January 8, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is likely part of this larger IDC. The contract award does not mention any set-aside requirements, indicating open competition.

Generated 4/8/25, 9:58 AM